BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6702135)

  • 1. [Blood prolactin level of breast and endometrial cancer patients during surgical intervention].
    Pozdniakov VV; Bobrov IuF; Gamaiunova VB; Evtiukhin AI; Frid IA
    Vopr Onkol; 1984; 30(2):9-14. PubMed ID: 6702135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mastectomy versus mastectomy plus adjuvant ovariectomy on prolactin response to TRH in breast cancer.
    Ayala D; Lissoni P; Archili C; Barni S; Roveda G; Giacomelli M; Bissi A
    J Biol Regul Homeost Agents; 1990; 4(4):150-2. PubMed ID: 2128988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour.
    Messina G; Lissoni P; Brivio F; Rovelli F; Fumagalli L; Bartolacelli E; Mazza U; Colombo E; Bertoglio A
    In Vivo; 2008; 22(6):845-8. PubMed ID: 19181018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastectomy stimulates prolactin release in breast cancer patients.
    Holtkamp W; Osterloh B; Rauschecker H; Nagel GA
    Anticancer Res; 1986; 6(4):725-7. PubMed ID: 3752952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa test to predict response of carcinoma of the breast to surgical ablation of endocrine glands.
    Minton JP; Dickey RP
    Surg Gynecol Obstet; 1973 Jun; 136(6):971-4. PubMed ID: 4703478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer].
    Korolev VI; Skliar SIu; Chebotareva ED; Akimova RN
    Vopr Onkol; 1986; 32(11):55-9. PubMed ID: 3788082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
    Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
    J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolactin and human cancer of the breast. I. Levels of correlation].
    Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer].
    Vasil'eva IA; Bershteĭn LM; Ostroumova MN; Dil'man VM
    Vopr Onkol; 1980; 26(9):34-6. PubMed ID: 7423902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of mastectomy on the prolactin level in the blood].
    Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):8-13. PubMed ID: 7219111
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.
    O'Byrne KJ; Dobbs N; Propper DJ; Braybrooke JP; Koukourakis MI; Mitchell K; Woodhull J; Talbot DC; Schally AV; Harris AL
    Br J Cancer; 1999 Mar; 79(9-10):1413-8. PubMed ID: 10188884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perioperative psychological status of patients undergoing radical mastectomy and total hysterectomy].
    Umegaki H; Minami C; Katou H; Kawasaki T; Fukunaga T; Shimizu A
    Masui; 1993 Apr; 42(4):523-8. PubMed ID: 8315793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can plasma prolactin predict tamoxifen resistance in patients with advanced breast cancer?
    Bhatavdekar JM; Patel DD; Karelia NH; Shah NG; Ghosh N; Vora HH; Suthar TP; Balar DB; Doctor SS
    Eur J Surg Oncol; 1994 Apr; 20(2):118-21. PubMed ID: 8181575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolactin and steroid hormones in the blood in local disorders of the lymph-plasma circulation in breast cancer patients].
    Berzin SA; Tokar' VN
    Sov Med; 1988; (12):16-9. PubMed ID: 3242113
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma].
    Pavić S; Pavić Z
    Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlations between prolactin and somatotropic hormone in human breast cancer].
    Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
    Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.